SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYGN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Carolyn who wrote (49)12/6/1999 7:42:00 PM
From: StaggerLee  Read Replies (1) of 135
 
Back of the envelope attempt at valuation:

Two million diabetics in the US (I think). If they get 10% market penetration, that's 200,000 customers paying $4/day for, say 300 days a year. That's revenues of $240 million. Gross it up by 20% for sales to hospitals/doctors, and you have $288 million.

Add to that watch sales: say 50,000 watches a year at $400 which is another $20 mill.

So, $308 million revenues at say 15% net margins. That's $46.2 million net income, or about $1.86/share. Give it a PE of 20, and you're looking at a $37 stock.

:) I don't own this one. Good luck to those who do.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News